Filter Results:
(2,715)
Show Results For
- All HBS Web
(5,672)
- People (18)
- News (2,029)
- Research (2,715)
- Events (7)
- Multimedia (222)
- Faculty Publications (1,997)
Show Results For
- All HBS Web
(5,672)
- People (18)
- News (2,029)
- Research (2,715)
- Events (7)
- Multimedia (222)
- Faculty Publications (1,997)
Sort by
- 13 Feb 2018
- First Look
New Research and Ideas, February 13, 2018
Case 118-051 Partners In Health: Costing Primary Care in Haiti Partners in Health, a global NGO focused on delivering health care to residents of rural underserved communities,... View Details
Keywords: Sean Silverthorne
- 16 May 2016
- HBS Case
Food Safety Economics: The Cost of a Sick Customer
Business School and Professor in Health Policy and Management at the Harvard T.H. Chan School of Public Health. Even though Chipotle’s supply chain is shorter, with fewer intermediaries between supplier and... View Details
- 14 Feb 2012
- First Look
First Look: February 14
individuals bring well-articulated preexisting preferences to such decisions. Understanding beliefs and attitudes motivating these preferences can assist physicians in helping parents make informed decisions consistent with their values. Consumer-Driven View Details
Keywords: Carmen Nobel
- 23 May 2017
- First Look
First Look at New Ideas and Research: May 23, 2017
practice. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=52649 Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spending By: Cutler, David,... View Details
Keywords: Carmen Nobel
- 11 Mar 2008
- First Look
First Look: March 11, 2008
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=808104 Partners in Health: The PACT Project Harvard Business School Case 608-065 Partners in Health (PIH) is a Boston-based, not-for-profit that provides View Details
Keywords: Martha Lagace
- 18 Aug 2009
- First Look
First Look: August 18
one mechanism for capturing the performance benefits of diversity in experience and provide insight into how the management of experience accumulation affects team performance. Download the paper: http://www.hbs.edu/research/pdf/09-145.pdf PublicationsInstitutional... View Details
Keywords: Martha Lagace
- January 2023 (Revised September 2024)
- Supplement
The END Fund (B)
By: V. Kasturi Rangan and Courtney Han
Founded in 2012, the END fund focused on eliminating five Neglected Tropical Diseases that accounted for 80% of the tropical diseases affecting nearly 1.5 billion people worldwide. Its roughly $25 million/year annual budget was fully committed when it got news that the... View Details
Keywords: Health Disorders; Investment Funds; Global Range; Nonprofit Organizations; Resource Allocation; Decisions; Health Care and Treatment; Mission and Purpose
Rangan, V. Kasturi, and Courtney Han. "The END Fund (B)." Harvard Business School Supplement 523-064, January 2023. (Revised September 2024.)
- 10 Jan 2017
- First Look
First Look at New Research: January 10, 2017
risk changing its business model or proceed with confidence? Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/217035-PDF-ENG Harvard Business School Case 517-070 Access Health CT: Marketing Affordable View Details
Keywords: Sean Silverthorne
- 2018
- Chapter
The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century
By: Nicholas Bagley, Benjamin Berger, Amitabh Chandra, Craig Garthwaite and Ariel Dora Stern
On the 35th anniversary of the adoption of the Orphan Drug Act (ODA), we describe the enormous changes in the markets for therapies for rare diseases that have emerged over recent decades. The most prominent example is the fact that the profit-maximizing price of new... View Details
Keywords: Health Care and Treatment; Laws and Statutes; Research and Development; Investment; Markets; Monopoly
Bagley, Nicholas, Benjamin Berger, Amitabh Chandra, Craig Garthwaite, and Ariel Dora Stern. "The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century." Chap. 4 in Innovation Policy and the Economy, Volume 19, edited by Josh Lerner and Scott Stern, 97–137. University of Chicago Press, 2018.
- February 2009
- Teaching Note
Examining the Adoption of Drug-Eluting Stents (TN)
By: Elie Ofek and Peter Wickersham
Teaching Note for [509028]. View Details
- January 2022 (Revised August 2022)
- Case
Hello Heart: The Next Generation of Chronic Disease Management Apps
By: Ariel D. Stern and Danielle Golan
Hello Heart, a hypertension management app debated whether to go deep and cover other heart conditions, or to expand its solution to other chronic conditions. View Details
Keywords: Health; Health Care and Treatment; Information Technology; Mobile and Wireless Technology; Analysis; Business Startups; Transition; Customer Focus and Relationships; Customer Satisfaction; Decision Making; Demographics; Design; Entrepreneurship; Venture Capital; Technological Innovation; Growth and Development Strategy; Product Launch; Product Design; Product Development; Business Strategy; Competitive Strategy; Competitive Advantage; Customization and Personalization; Business Growth and Maturation; Business Model; Strategy; Applications and Software; Health Industry; Health Industry; Israel; United States
Stern, Ariel D., and Danielle Golan. "Hello Heart: The Next Generation of Chronic Disease Management Apps." Harvard Business School Case 622-061, January 2022. (Revised August 2022.)
- 26 Jun 2012
- First Look
First Look: June 26
by a public health organization are randomly allocated to four groups. Agents in the control group receive a standard volunteer contract often offered for this type of task, whereas agents in the three treatment groups receive small... View Details
Keywords: Sean Silverthorne
- March 17, 2017
- Article
How Economics Can Shape Precision Medicines
By: Ariel Dora Stern, Brian M. Alexander and Amitabh Chandra
Many public and private efforts in coming years will focus on research in precision medicine, developing biomarkers to indicate which patients are likely to benefit from a certain treatment so that others can be spared the cost—financial and physical—of being treated... View Details
Stern, Ariel Dora, Brian M. Alexander, and Amitabh Chandra. "How Economics Can Shape Precision Medicines." Science 355, no. 6330 (March 17, 2017): 1131–1133.
- September 2021 (Revised October 2022)
- Supplement
Hester Pharmaceuticals (B): Securing Supply
By: Dante Roscini and John Masko
Supplements the (A) case. In late 2020, demand for Hester Pharmaceutical’s (Hester’s) breakthrough oncology drug Akrozumab was outstripping the company’s most optimistic projections. In order to increase manufacturing capacity and meet the demand, Hester was... View Details
Keywords: COVID-19 Pandemic; Cost vs Benefits; Trade; Supply Chain; Global Strategy; Buildings and Facilities; Operations; Health Care and Treatment; Demand and Consumers; Global Range; Globalized Markets and Industries; Pharmaceutical Industry; Italy; China; United States; Germany
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (B): Securing Supply." Harvard Business School Supplement 722-009, September 2021. (Revised October 2022.)
- June 2000
- Case
Lifeline Systems, Inc. (A)
By: H. Kent Bowen and Marilyn Matis
Lifeline Systems provides emergency response equipment to the elderly who live at home. The company uses local hospitals to market, sell, and install these units in homes, while the hospital monitors and calls for aid to respond to emergency calls from the elderly... View Details
Keywords: Health Care and Treatment; Product Marketing; Sales; Problems and Challenges; Growth and Development Strategy; Managerial Roles; Service Operations; Information Infrastructure; Age; Service Delivery; Restructuring; Crisis Management; Health Industry; Health Industry
Bowen, H. Kent, and Marilyn Matis. "Lifeline Systems, Inc. (A)." Harvard Business School Case 600-099, June 2000.
- 25 Feb 2015
- Lessons from the Classroom
Scholars and Students Unpack the Digital Business Revolution
article The Capitalist's Dilemma.) More recently, HBS's Health Care and Digital initiatives collaborated on the Health Acceleration Challenge to identify proven innovations... View Details
- 22 Apr 2008
- First Look
First Look: April 22, 2008
Working PapersThe 'Thin Film of Gold': Monetary Rules and Policy Credibility In Developing Countries Authors:Niall Ferguson and Moritz Schularick Abstract This paper asks whether developing countries can reap credibility gains from... View Details
Keywords: Martha Lagace
- 03 Dec 2015
- Op-Ed
How "New Nuclear" Power Could Save the Planet—If Regulators Would Allow It
what I perceive as failures of national policy and common sense. I hate to see big business opportunities slip through our fingers. However, I believe that these new nuclear ventures should go wherever they need to go to make progress and... View Details
- November 2020
- Supplement
Improving Access at VA (Update)
By: Ryan W. Buell
In November 2020, Chief Veterans Experience Officer, Lynda Davis, and Deputy Chief Veterans Experience Officer, Barbara C. Morton reflect on a busy four years leading the Veterans Experience Office at the U.S. Department of Veterans Affairs. The case provides an update... View Details
Keywords: Government; Service Management; Leading Change; Transformation; Service Operations; Management; Health Care and Treatment; Government Administration; Performance Improvement; Public Administration Industry; United States
Buell, Ryan W. "Improving Access at VA (Update)." Harvard Business School Supplement 621-070, November 2020.
- January 2014 (Revised June 2014)
- Supplement
23andMe: Genetic Testing for Consumers (B)
By: John A. Quelch and Margaret L. Rodriguez
Following the FDA's letter in November 2013, which ordered 23andMe to cease sales of its DNA test kits, observers wondered how co-founder and CEO, Anne Wojcicki, would guide the company in the presence of uncertainty. View Details
Keywords: Risk and Uncertainty; Genetics; Crisis Management; Health Care and Treatment; Product Development; Business and Government Relations; Biotechnology Industry; Consumer Products Industry; United States
Quelch, John A., and Margaret L. Rodriguez. "23andMe: Genetic Testing for Consumers (B)." Harvard Business School Supplement 514-095, January 2014. (Revised June 2014.)